6 Months for €18.50
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC
Mon, 17 Jul, 2023
Leading US generic drugmaker Perrigo has formally completed its $8.6bn (€6.5bn) takeover of Irish biotech firm Elan in a cash and share deal.
Fri, 20 Dec, 2013
US pharmaceutical Perrigo will benefit from around $150m (€113m) in annual tax savings from acquiring Elan, its chief executive said yesterday.
Tue, 30 Jul, 2013
News
Friday, September 25, 2026 - 12:00 PM
Friday, September 25, 2026 - 9:00 AM
Thursday, September 24, 2026 - 6:00 PM